Aqueous Versus Aerosol Intranasal Corticosteroid Spray for Allergic Rhinitis: Systematic Review and Meta-Analysis
American Journal of Rhinology & Allergy · 2025
DOI: 10.1177/19458924251360917 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift American Journal of Rhinology & Allergy, 2025. Verfasst von Dylan A Levy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Tulane University School of Medicine, New Orleans, LA, USA. Hauptthemen laut MEDLINE: Rhinitis, Allergic, Adrenal Cortex Hormones. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
Background
Allergic rhinitis (AR) affects millions of people worldwide, impacting quality of life and causing economic burden. Intranasal corticosteroids (INCs) are the mainstay treatment for AR, delivered via aerosol or aqueous sprays.
Objective
This systematic review and meta-analysis investigate the comparative efficacy and safety of aerosol and aqueous delivery methods in AR treatment.
Methods
Two independent reviewers searched 4 databases (Embrace, Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, and Web of Science) for English-language, prospective randomized controlled trial (RCT), comparing aqueous and aerosol INCs for AR treatment. Studies were excluded for specific reasons (wrong comparisons, full text unavailable, insufficient data for extraction, wrong patient population, incorrect route of administration (non-intranasal), unverifiable inclusion criteria). Primary outcomes were Total Nasal Symptom Score (TNSS) and subset scores; secondary outcome was adverse event (AEs).
Results
No significant difference in overall TNSS was found between the delivery methods. However, aqueous sprays showed a slight edge in reducing specific symptoms like congestion, itching, sneezing, and rhinorrhea. AEs did not differ significantly.
Conclusion
Our findings suggest no significant difference in efficacy or safety between aerosol and aqueous INCs for AR treatment. Patient preference should be a primary consideration when choosing a delivery method to optimize adherence and symptom control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology, Tulane University School of Medicine, New Orleans, LA, USA.
- Tulane University School of Medicine, New Orleans, LA, USA.
- Department of Otorhinolaryngology, Ochsner Health, New Orleans, LA, USA.
ORCID-Profile: Ajibola B Bakare
Zitieren
APA
Levy, D. A., Bakare, A. B., Gurevich, R. E., & McCoul, E. D. (2025). Aqueous Versus Aerosol Intranasal Corticosteroid Spray for Allergic Rhinitis: Systematic Review and Meta-Analysis. American Journal of Rhinology & Allergy. https://doi.org/10.1177/19458924251360917
Vancouver
Levy DA, Bakare AB, Gurevich RE, McCoul ED. Aqueous Versus Aerosol Intranasal Corticosteroid Spray for Allergic Rhinitis: Systematic Review and Meta-Analysis. American Journal of Rhinology & Allergy. 2025. doi:10.1177/19458924251360917
BibTeX
@article{Levy2025,
author = {Levy, Dylan A and Bakare, Ajibola B and Gurevich, Robert E and McCoul, Edward D},
title = {Aqueous Versus Aerosol Intranasal Corticosteroid Spray for Allergic Rhinitis: Systematic Review and Meta-Analysis},
journal = {American Journal of Rhinology & Allergy},
year = {2025},
doi = {10.1177/19458924251360917}
}
EUVIMED